HOXB9 and hepatocellular carcinoma: Consistent with our study, a previous study by Chiba et al. has identified that HOXB9 was upregulated in HCC tissues and increased HOXB9 levels in HCC predicts poor overall survival, but a beneficial response to sorafenib [24].